Dual therapy with raltegravir plus a fixed dose combination of darunavir/ritonavir in people living with HIV in Argentina

OBJECTIVE: There are generic fixed-dose combinations (FDCs) of ritonavir-boosted darunavir (DRV/r) available in Argentina. Experiences with these FDCs in dual therapy remain limited in clinical practice. We aimed to describe clinical and virologic outcomes in patients exposed to FDC DRV/r + raltegra...

Descripción completa

Detalles Bibliográficos
Autores principales: Rombini, Fernanda, Cecchini, Diego M., Ballivian, Jamile, Huberman, Mara, Urueña, Analía, Cassetti, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876904/
https://www.ncbi.nlm.nih.gov/pubmed/33267555
http://dx.doi.org/10.37201/req/090.2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876904/
https://www.ncbi.nlm.nih.gov/pubmed/33267555
http://dx.doi.org/10.37201/req/090.2020

Ejemplares similares